[Federal Register Volume 71, Number 148 (Wednesday, August 2, 2006)]
[Notices]
[Page 43814]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-12457]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 27, 2006, Noramco Inc., 
1440 Olympic Drive, Athens, Georgia 30601, made application by letter 
to the Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of basic drug code (1724) methylphenidate.
    The company plans to bulk manufacture methylphenidate for a 
customer to use in the production of a controlled substance product.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC. 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Representative/ODL, 2401 
Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed 
no later than October 2, 2006.

    Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E6-12457 Filed 8-1-06; 8:45 am]
BILLING CODE 4410-09-P